Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
13.7 SEK | +1.48% | +14.17% | +72.33% |
25/04 | Arcoma AB Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
29/01 | Arcoma AB Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Sales 2024 * | 183M 16.75M 1.4B | Sales 2025 * | 199M 18.22M 1.52B | Capitalization | 178M 16.3M 1.36B |
---|---|---|---|---|---|
Net income 2024 * | 14M 1.28M 107M | Net income 2025 * | 16M 1.46M 122M | EV / Sales 2024 * | 0.93 x |
Net cash position 2024 * | 7M 641K 53.46M | Net cash position 2025 * | 19M 1.74M 145M | EV / Sales 2025 * | 0.8 x |
P/E ratio 2024 * |
13.1
x | P/E ratio 2025 * |
11.2
x | Employees | 31 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 53.16% |
1 day | +1.48% | ||
1 week | +14.17% | ||
Current month | +15.13% | ||
1 month | +16.10% | ||
3 months | +44.21% | ||
6 months | +71.25% | ||
Current year | +72.33% |
Managers | Title | Age | Since |
---|---|---|---|
Johan Dahlberg
DFI | Director of Finance/CFO | 40 | 01/22/01 |
Chief Tech/Sci/R&D Officer | 53 | 01/14/01 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 57 | - | |
Director/Board Member | 53 | 01/10/01 | |
Lars Kvarnhem
CHM | Chairman | 52 | 01/17/01 |
Date | Price | Change | Volume |
---|---|---|---|
29/24/29 | 13.7 | +1.48% | 17 057 |
26/24/26 | 13.5 | +2.66% | 103,388 |
25/24/25 | 13.15 | +12.88% | 363,784 |
24/24/24 | 11.65 | -2.10% | 49,419 |
23/24/23 | 11.9 | -0.83% | 10,220 |
Delayed Quote Nasdaq Stockholm, April 29, 2024 at 01:06 pm IST
More quotesEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+72.33% | 16.24M | |
-5.77% | 14.6B | |
-40.71% | 2.71B | |
-12.92% | 2.44B | |
-8.78% | 1.51B | |
-.--% | 1.12B | |
+40.66% | 518M | |
+10.95% | 239M | |
+1.67% | 183M | |
-.--% | 168M |
- Stock Market
- Equities
- ARCOMA Stock